Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Deraco

Showing results (141-150 of 178) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experienceTristan D Yan, Marcello Deraco, Dario Baratti, et al.
Oncotarget|October 6, 2016
Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition frameworkFabio Bozzi, Silvia Brich, Gian Paolo Dagrada, et al.
Biomedicines|July 29, 2023
A2AR Expression and Immunosuppressive Environment Independent of <i>KRAS</i> and <i>GNAS</i> Mutations in Pseudomyxoma PeritoneiShigeki Kusamura, Adele Busico, Elena Conca, et al.
The Oncologist|June 22, 2014
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxomaFilippo Pietrantonio, Claudia Maggi, Giuseppe Fanetti, et al.
Annals of Surgical Oncology|May 31, 2021
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'Luigi Marano, Daniele Marrelli, Paolo Sammartino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 8, 2020
Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncologyAntonio Sommariva, Luca Ansaloni, Gian Luca Baiocchi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 2, 2024
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedsideLuca Varinelli, Davide Battistessa, Marcello Guaglio, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2024
Correction: Colorectal carcinoma peritoneal metastases‑derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench‑to‑bedsideLuca Varinelli, Davide Battistessa, Marcello Guaglio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2024
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Journal of Translational Medicine|May 8, 2016
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational studyFilippo Pietrantonio, Rosa Berenato, Claudia Maggi, et al.
Pageof 18

Showing results (141-150 of 178) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experienceTristan D Yan, Marcello Deraco, Dario Baratti, et al.
Oncotarget|October 6, 2016
Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition frameworkFabio Bozzi, Silvia Brich, Gian Paolo Dagrada, et al.
Biomedicines|July 29, 2023
A2AR Expression and Immunosuppressive Environment Independent of <i>KRAS</i> and <i>GNAS</i> Mutations in Pseudomyxoma PeritoneiShigeki Kusamura, Adele Busico, Elena Conca, et al.
The Oncologist|June 22, 2014
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxomaFilippo Pietrantonio, Claudia Maggi, Giuseppe Fanetti, et al.
Annals of Surgical Oncology|May 31, 2021
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'Luigi Marano, Daniele Marrelli, Paolo Sammartino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 8, 2020
Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncologyAntonio Sommariva, Luca Ansaloni, Gian Luca Baiocchi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 2, 2024
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedsideLuca Varinelli, Davide Battistessa, Marcello Guaglio, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2024
Correction: Colorectal carcinoma peritoneal metastases‑derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench‑to‑bedsideLuca Varinelli, Davide Battistessa, Marcello Guaglio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2024
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Journal of Translational Medicine|May 8, 2016
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational studyFilippo Pietrantonio, Rosa Berenato, Claudia Maggi, et al.
Pageof 18